Estimates Revisions Middle East Pharmaceutical Industries Company
Stocks
4016
SA160G51UO10
Pharmaceuticals
|
Market Closed -
Saudi Arabian S.E.
20:20:00 07/10/2026 HKT
|
5-day change | 1st Jan Change | ||
| 64.15 SAR | +0.47% |
|
+1.58% | +0.96% |
| 01:40pm | Avalon Pharma, Aurisco to Cooperate on Oligonucleotide Manufacturing in Saudi Arabia | MT |
| 09-17 | Avalon Pharma Renews SAR104 Million Bank Facility Deal with Banque Saudi Fransi | MT |
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- 4016 Stock
- Consensus Middle East Pharmaceutical Industries Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
